As different countries start the process of vaccinating their populations against COVID-19, some struggle with critical issues like vaccine hesitancy. It is vital to ensure adequate demand for vaccination to achieve herd immunity, whereby 70 to 85 percent of the population must be vaccinated. To do this, governments and health organizations must understand and identify the different – and complex – causes of vaccine hesitancy, and design scalable solutions to minimize hesitancy and its consequences as rapidly as possible.
Please join Chemonics and the Global Health Supply Chain Summit Group for a virtual panel discussion bringing together practitioners, community leaders, and other critical stakeholders to share insights regarding community objections to COVID-19 vaccinations and key considerations for health systems to ensure vaccine uptake.
The panel discussion will be recorded and made available to registrants.
- Dr. Katherine Bliss, Senior Fellow, Global Health Policy Center, Center for Strategic and International Studies
- Rev. David Oginde, Former Presiding Bishop, Christ Is the Answer Ministries, Chancellor of Pan Africa Christian University
- Dr. Githinji Gitahi, Global CEO, Amref Health Africa
- Dr. John Oladejo, Director for Health Emergency Preparedness and Response at the Nigeria Centre for Disease Control
- Dr. Baz Semo, Managing Director, Global Health Programs, Global Health Division, Chemonics International
- Dr. Noel Watson, Principal/Founder, OpsMend